Mercurna is a Netherlands-based biotech startup developing messenger RNA (mRNA) based medicines. To that end we are continuously perfecting our platform technology which combines unique cell-targeting ligands, with a proprietary lipid-based delivery vehicle to deliver engineered mRNA with high efficiency and high specificity to the diseased tissues. We leverage this platform in our pursuit of various life-changing medicines.
We are in particular determined to deliver first-of-its-kind precision medicines for inflammatory diseases, with a current focus on (chronic) kidney disease.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Kloosterstraat 9, Re0333/re0207,netherlands
- in****@****rna.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- mercurna.com
- HQ
- Oss, Gelderland
Mercurna Questions
Mercurna's website is mercurna.com
Mercurna's LinkedIn profile is https://nl.linkedin.com/company/mercurna
Mercurna has
6 employees.
View email and phone details for 6
employees at Mercurna.
Mercurna's industry is
Biotechnology Research
Mercurna's top competitors are
Innatoss Laboratories,
Cell4pharma,
Synaffix,
Ribopro,
Citryll,
Crossfire Oncology,
Pivot Park,
Predica Diagnostics Bv,
Orgestra,
Byondis.
Mercurna's support email address is info@mercurna.com
Mercurna's categories are Biotechnology Research
Mercurna's founding year is 2017
